Spyre Therapeutics to participate in upcoming September investor conferences
Spyre Therapeutics (NASDAQ:SYRE) says it will participate in upcoming September investor conferences, according to a Globe Newswire update from Waltham, Massachusetts.
WALTHAM, Mass., Sept.
03, 2026 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc.
NASDAQ:SYRE, a clinical-stage biotechnology company committed to developing next-generation therapies that elevate the standard in immunology by delivering more complete disease control, greater durability, and a simpler tr…